Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration

Fig. 1

Characterization of automatically generated fractions. Cell product (CP), non-target cell bag (NTCB), waste bag (WB) and bone marrow (BM) were analyzed in respect of their CD45+ cells/μl (a), CD133+CD34+ cells/μl (b) and viability of CD45+ cells (c) using flow cytometry measurement in accordance with ISHAGE guidelines. Additionally, total numbers of thrombocytes (d) and erythrocytes (e) were assessed using a Sysmex device. All data are presented as mean ± SEM. CP, BM (n = 6); NTCB, WB (n = 3). *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 vs. CP

Back to article page